NBE-002 in Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Advanced Cancer|Triple Negative Breast Cancer
Interventions: DRUG: NBE-002
Sponsor: NBE-Therapeutics AG
Collaborators: Cmed Clinical Services